2 citations · 2 across the 4 of their papers we have counts for
1 paper · 1 filter
Vic Norton
We use the 2014 market history of two high-returning biotechnology exchange-traded funds to illustrate how ex post mean-variance analysis should not be done. Unfortunately, the way…